100 related articles for article (PubMed ID: 31091402)
1. Right sizing for vaccine effectiveness studies: how many is enough for reliable estimation?
Price OH; Carville KS; Sullivan SG
Commun Dis Intell (2018); 2019 May; 43():. PubMed ID: 31091402
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
[TBL] [Abstract][Full Text] [Related]
3. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.
Valenciano M; Kissling E; Cohen JM; Oroszi B; Barret AS; Rizzo C; Nunes B; Pitigoi D; Larrauri Cámara A; Mosnier A; Horvath JK; O'Donnell J; Bella A; Guiomar R; Lupulescu E; Savulescu C; Ciancio BC; Kramarz P; Moren A
PLoS Med; 2011 Jan; 8(1):e1000388. PubMed ID: 21379316
[TBL] [Abstract][Full Text] [Related]
4. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
[TBL] [Abstract][Full Text] [Related]
7. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.
Castilla J; Martínez-Baz I; Martínez-Artola V; Reina G; Pozo F; García Cenoz M; Guevara M; Morán J; Irisarri F; Arriazu M; Albéniz E; Ezpeleta C; Barricarte A; ;
Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399423
[TBL] [Abstract][Full Text] [Related]
8. Pilot to evaluate the feasibility of measuring seasonal influenza vaccine effectiveness using surveillance platforms in Central-America, 2012.
El Omeiri N; Azziz-Baumgartner E; Clará W; Guzmán-Saborío G; Elas M; Mejía H; Molina IB; De Molto Y; Mirza S; Widdowson MA; Ropero-Álvarez AM
BMC Public Health; 2015 Jul; 15():673. PubMed ID: 26184659
[TBL] [Abstract][Full Text] [Related]
9. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.
Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA
Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093
[TBL] [Abstract][Full Text] [Related]
10. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
[TBL] [Abstract][Full Text] [Related]
11. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.
Kissling E; Valenciano M; Cohen JM; Oroszi B; Barret AS; Rizzo C; Stefanoff P; Nunes B; Pitigoi D; Larrauri A; Daviaud I; Horvath JK; O'Donnell J; Seyler T; Paradowska-Stankiewicz IA; Pechirra P; Ivanciuc AE; Jiménez-Jorge S; Savulescu C; Ciancio BC; Moren A
PLoS One; 2011; 6(11):e27622. PubMed ID: 22110695
[TBL] [Abstract][Full Text] [Related]
12. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.
Sullivan SG; Komadina N; Grant K; Jelley L; Papadakis G; Kelly H
J Med Virol; 2014 Jun; 86(6):1017-25. PubMed ID: 24395730
[TBL] [Abstract][Full Text] [Related]
14. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
[TBL] [Abstract][Full Text] [Related]
15. Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
Lane CR; Carville KS; Pierse N; Kelly HA
Vaccine; 2016 Feb; 34(8):1070-6. PubMed ID: 26795366
[TBL] [Abstract][Full Text] [Related]
16. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
17. Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.
Jimenez-Jorge S; de Mateo S; Delgado-Sanz C; Pozo F; Casas I; Garcia-Cenoz M; Castilla J; Rodriguez C; Vega T; Quinones C; Martinez E; Vanrell JM; Gimenez J; Castrillejo D; Altzibar JM; Carril F; Ramos JM; Serrano MC; Martinez A; Torner N; Perez E; Gallardo V; Larrauri A;
Euro Surveill; 2015 Jul; 20(28):. PubMed ID: 26212144
[TBL] [Abstract][Full Text] [Related]
18. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.
Nunes B; Machado A; Guiomar R; Pechirra P; Conde P; Cristovão P; Falcão I
Vaccine; 2014 Jul; 32(35):4443-4449. PubMed ID: 24962756
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.
Levy A; Sullivan SG; Tempone SS; Wong KL; Regan AK; Dowse GK; Effler PV; Smith DW
Vaccine; 2014 Oct; 32(47):6312-8. PubMed ID: 25223268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
